Google Analytics

Friday, July 31, 2020

FDA Approves Triple Drug Combo for Melanoma


The triple-therapy combination of atezolizumab plus cobimetinib and vemurafenib is now approved for BRAF....

https://www.medscape.com/viewarticle/934934

No comments:

Post a Comment

Popular B Media Network Health News Editor Posts